Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab
2005 · Cancer Immunology Immunotherapy · 313 citations
https://doi.org/10.1007/s00262-005-0058-x
K
Kathleen McKeever
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
1.0K
Citations
14
h-index
16
i10-index
Kathleen McKeever is an academic researcher from Southern Research Station. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & T-cell and B-cell Immunology & Biosimilars and Bioanalytical Methods. The author has an h-index of 14, co-authored 29 publications.
ORCID: 0000-0001-8827-8258Papers by this author
worksSafety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study
2016 · Arthritis Research & Therapy · 78 citations
https://doi.org/10.1186/s13075-016-1021-2
Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials
2018 · Clinical Pharmacokinetics · 21 citations
https://doi.org/10.1007/s40262-018-0721-y
Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques
2023 · Gene Therapy · 7 citations
https://doi.org/10.1038/s41434-023-00423-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat